Black Friday Savings ! Exclusive Deals on Latest Pharma and Medical Technology Reports.

Explore Now
  • Home
  • Report Store
  • Primary Open Angle Glaucoma (POAG) - Epidemiology Forecast to 2030

Primary Open Angle Glaucoma Poag Epidemiology Forecast

DelveInsight's 'Primary Open Angle Glaucoma (POAG) - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Primary Open Angle Glaucoma (POAG) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Primary Open Angle Glaucoma (POAG) Understanding

The DelveInsight Primary Open Angle Glaucoma (POAG) epidemiology report gives a thorough understanding of the Primary Open Angle Glaucoma (POAG) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Primary Open Angle Glaucoma (POAG) in the US, Europe, and Japan. The report covers the detailed information of the Primary Open Angle Glaucoma (POAG) epidemiology scenario in seven major countries (US, EU5, and Japan).


Primary Open Angle Glaucoma (POAG) Epidemiology Perspective by DelveInsight

The Primary Open Angle Glaucoma (POAG) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Primary Open Angle Glaucoma (POAG) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Primary Open Angle Glaucoma (POAG) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Primary Open Angle Glaucoma (POAG) Detailed Epidemiology Segmentation

The Primary Open Angle Glaucoma (POAG) epidemiology covered in the report provides historical as well as forecasted Primary Open Angle Glaucoma (POAG) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Primary Open Angle Glaucoma (POAG) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Primary Open Angle Glaucoma (POAG) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Primary Open Angle Glaucoma (POAG) Epidemiology Report and Model provide an overview of the risk factors and global trends of Primary Open Angle Glaucoma (POAG) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Primary Open Angle Glaucoma (POAG) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Primary Open Angle Glaucoma (POAG)
  • The report provides the segmentation of the Primary Open Angle Glaucoma (POAG) epidemiology


Report Highlights

  • 11-Year Forecast of Primary Open Angle Glaucoma (POAG) epidemiology
  • 7MM Coverage
  • Total Cases of Primary Open Angle Glaucoma (POAG)
  • Total Cases of Primary Open Angle Glaucoma (POAG) according to segmentation
  • Diagnosed cases of Primary Open Angle Glaucoma (POAG)


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Primary Open Angle Glaucoma (POAG)?
  • What are the key findings pertaining to the Primary Open Angle Glaucoma (POAG) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Primary Open Angle Glaucoma (POAG) across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Primary Open Angle Glaucoma (POAG)?
  • What are the currently available treatments of Primary Open Angle Glaucoma (POAG)?


Reasons to buy

  • The Primary Open Angle Glaucoma (POAG) Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Primary Open Angle Glaucoma (POAG) market
  • Quantify patient populations in the global Primary Open Angle Glaucoma (POAG) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Primary Open Angle Glaucoma (POAG) therapeutics in each of the markets covered
  • Understand the magnitude of Primary Open Angle Glaucoma (POAG) population by its epidemiology
  • The Primary Open Angle Glaucoma (POAG) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Primary Open Angle Glaucoma (POAG)

3. Primary Open Angle Glaucoma (POAG): Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Primary Open Angle Glaucoma (POAG) Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Primary Open Angle Glaucoma (POAG) Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Primary Open Angle Glaucoma (POAG) Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Primary Open Angle Glaucoma (POAG) Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Primary Open Angle Glaucoma (POAG) Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Primary Open Angle Glaucoma (POAG) Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Primary Open Angle Glaucoma (POAG) Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Primary Open Angle Glaucoma (POAG) Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Primary Open Angle Glaucoma (POAG) Treatment and Management

6.2. Primary Open Angle Glaucoma (POAG) Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Primary Open Angle Glaucoma (POAG) Epidemiology in 7MM (2017-2030)

Table 2 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Primary Open Angle Glaucoma (POAG) Epidemiology in the United States (2017-2030)

Table 4 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Primary Open Angle Glaucoma (POAG) Epidemiology in Germany (2017-2030)

Table 6 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Primary Open Angle Glaucoma (POAG) Epidemiology in France (2017-2030)

Table 8 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Primary Open Angle Glaucoma (POAG) Epidemiology in Italy (2017-2030)

Table 10 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Primary Open Angle Glaucoma (POAG) Epidemiology in Spain (2017-2030)

Table 12 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Primary Open Angle Glaucoma (POAG) Epidemiology in the United Kingdom (2017-2030)

Table 14 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Primary Open Angle Glaucoma (POAG) Epidemiology in Japan (2017-2030)

Table 16 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Primary Open Angle Glaucoma (POAG) Epidemiology in 7MM (2017-2030)

Figure 2 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Primary Open Angle Glaucoma (POAG) Epidemiology in the United States (2017-2030)

Figure 4 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Primary Open Angle Glaucoma (POAG) Epidemiology in Germany (2017-2030)

Figure 6 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Primary Open Angle Glaucoma (POAG) Epidemiology in France (2017-2030)

Figure 8 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Primary Open Angle Glaucoma (POAG) Epidemiology in Italy (2017-2030)

Figure 10 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Primary Open Angle Glaucoma (POAG) Epidemiology in Spain (2017-2030)

Figure 12 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Primary Open Angle Glaucoma (POAG) Epidemiology in the United Kingdom (2017-2030)

Figure 14 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Primary Open Angle Glaucoma (POAG) Epidemiology in Japan (2017-2030)

Figure 16 Primary Open Angle Glaucoma (POAG) Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



Forward to Friend

Add another person

Need A Quote